Atherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a significant caused of cardiovascular events. A key process in atherosclerosis is the endothelial-to-mesenchymal transition (endmt), which involves the transformation of endothelial cells into mesenchymal cells, contriy Ar dysfunction.

The novel anthraquinone compound kanglexin (klx) has been investigated for its potential to prevent endmt in atherosclerosis by targeting 1/Transforming Growth Factor-Beta (TGFβ) Signaling Pathway.

A new study by researchers from Harbin Medical University, In China, Provides Insights Into The Molecular Mecular Mechanisms Underling The Protective Effects of Klx Against ENDMT and AGIINSCLEROTICROTION The paper is Published in the journey Frontiers of Medicine,

The research focused on the effects of klx on human umbilical Vein Endothelial Cells (HUVECs) Subjected to Tgfβ1-Induced Enduced Endus and on Atherosclerotic Lessions in Apoe—MCE FED-FED AIIT DIET DIET DIET DIET DIET DIET DIE Klx was found to Mitigate Morphological Changes, Reduce Collagen Synthesis, and Restore intercellular Connectivity in TGFβ1-Induced Huvecs.

It also attensuated the downregulation of endothelial markers and the upregulation of mesenchymal markers, indicating its potential to inhibit endmt. In Vivo, Klx Treatment Reduced Lipid Deposation, Plaque Formation, and Collagen Secretion in the aortic roots of mice, suggesting its efficacy in alleviating an alleviating aortic endmt and atherosclerosis.

The study further explred the molecular mechanisms of klx’s action, revealing that Klx Activates FGFR1, which in turn activates Map4K4, Leading to the inactivation of Inactivation of Integrin Erita . This Cascade of Events Results in the inhibit of Endmt.

The activation of FGFR1 by Klx was confirmed through the observation of increasing interactions Between phosphorylated FGFR1 and Map4K4, and the Inhibition of the inhibiting by a fgfr1 inhibitor reviews. These findings highlight the role of klx in modulating key signaling pathways involved in Endmt and Atherosclerosis, offering a potential theraputic strategy for these condits.

In conclusion, Klx exhibits protective Effects aganst and atherosclerosis by activating the FGFR1/Map4K4 Pathway and Suppressing The Integrin This Study’s Findings Position Klx as a Promising Candidate for the Prevention and Treatment of Vascular Endmt and Atherosclerosis, with Potential Clinical Applications in Managing Cardiovascular disases.

Provided by frontiers journey